Disclosures for "Identification of DAGLA as an Autoantibody Target in Cerebellar Ataxia"
-
Dr. Weiss has received personal compensation for serving as an employee of EUROIMMUN US.
-
Ramona Miske has received personal compensation for serving as an employee of Euroimmun. Ramona Miske has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Scharf has received personal compensation for serving as an employee of Euroimmun AG.
-
Mrs. Borowski has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
-
Mrs. Rochow has received personal compensation for serving as an employee of Euroimmun.
-
Dr. Radzimski has received personal compensation for serving as an employee of EUROIMMUN AG.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Thomas Skripuletz has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Alnylam Pharmaceuticals, Biogen, Centogene, CSL Behring, Grifols, Hexal AG, Janssen-Cilag, Merck Serono, Novartis, Roche, Sanofi, Swedish Orphan Biovitrum, Viatris. Thomas Skripuletz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for from Alexion, Alnylam Pharmaceuticals, argenx, Bayer Vital, Biogen, Bristol Myers Squibb, Celgene, Centogene, CSL Behring, Euroimmun, Grifols, Hexal AG, Horizon, Janssen-Cilag, Merck Serono, Novartis, Pfizer, Roche, Sanofi, Siemens, Swedish Orphan Biovitrum, Teva, Viatris.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Guerti has nothing to disclose.
-
Dr. Oyaert has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Prof. Wandinger has nothing to disclose.
-
Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Vincent Van Pesch, MD, PhD has received research support from Biogen.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Lars Komorowski has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for EUROIMMUN . Lars Komorowski has stock in Revvity. Lars Komorowski has received intellectual property interests from a discovery or technology relating to health care.
-
Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Kurt-Wolfram Suhs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Kurt-Wolfram Suhs has received research support from Bristol Myers Squibb.